Essential Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.66K Buy
304
+1
+0.3% +$22 ﹤0.01% 1286
2026
Q1
$5.26K Buy
303
+123
+68% +$2.33K ﹤0.01% 1546
2025
Q4
$3.39K Buy
180
+45
+33% +$754 ﹤0.01% 1590
2025
Q3
$1.96K Hold
135
﹤0.01% 1795
2025
Q2
$2.64K Buy
+135
New +$2.4K ﹤0.01% 1241

Other funds holding CDNA

Essential Partners's CDNA Position: Q2 2026 in Review

Essential Partners increased its CareDx (CDNA) stake by 0.33% in Q2 2026, buying an estimated $22 and bringing the position to 304 shares worth $8.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Essential Partners first reported a position in CDNA in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Essential Partners held 304 shares of CareDx worth $8.66K as of Q2 2026.
  • Essential Partners bought 1 CareDx share in Q2 2026, an estimated $22.
  • CareDx made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1286 holding.
  • Essential Partners first reported a position in CareDx in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.